GSK plc GSK announced that the European Medicines Agency has accepted its marketing authorization application (MAA) seeking approval of its investigational ileal bile acid transporter (“IBAT”) ...

Cholangitis is inflammation in your bile ducts that, without treatment, can lead to serious health issues. Cholangitis is a type of liver disease that causes inflammation (swelling) in the bile ...

Cholangitis describes inflammation in the bile ducts or biliary system. Some forms of cholangitis can be life threatening. Treatment may involve antibiotics, drainage of the bile duct, and ...

Some ESPN FC viewers have noticed in recent months that studio host Dan Thomas’s eyes would often appear yellow or discolored ...

Cholangitis and cholecystitis are two separate conditions that affect the biliary system. While both can be related to gallstones, they each have different underlying causes, symptoms, and treatments.

Primary sclerosing cholangitis, PSC in short, is a rare liver disease that destroys the bile ducts. It is a severe condition ...

EMA accepts GSK’s MAA for linerixibat for cholestatic pruritus in patients with primary biliary cholangitis: London, UK Tuesday, June 24, 2025, 09:00 Hrs [IST] GSK plc announced ...

Secondary sclerosing cholangitis is a chronic cholestatic biliary disease, which unlike primary sclerosing cholangitis, is thought to develop as a consequence of known injuries. The presence of ...

Journalist Annie Lowrey suffers from primary biliary cholangitis (PBC), a degenerative liver disease in which the body mistakenly attacks cells lining the bile ducts, causing them to inflame.

Primary sclerosing cholangitis (PSC) is a chronic progressive liver disease that affects the bile ducts. About 40% of people will need a liver transplant.